WO2005032636A1 - Catheter balloons comprising an energy-conductive hydrophilic polymer - Google Patents

Catheter balloons comprising an energy-conductive hydrophilic polymer Download PDF

Info

Publication number
WO2005032636A1
WO2005032636A1 PCT/US2004/029059 US2004029059W WO2005032636A1 WO 2005032636 A1 WO2005032636 A1 WO 2005032636A1 US 2004029059 W US2004029059 W US 2004029059W WO 2005032636 A1 WO2005032636 A1 WO 2005032636A1
Authority
WO
WIPO (PCT)
Prior art keywords
balloon
conductive
balloon catheter
hydrophilic polymer
catheter
Prior art date
Application number
PCT/US2004/029059
Other languages
French (fr)
Inventor
Gregory R. Eberl
Mark Forrest
Original Assignee
Scimed Life Systems, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scimed Life Systems, Inc. filed Critical Scimed Life Systems, Inc.
Publication of WO2005032636A1 publication Critical patent/WO2005032636A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1027Making of balloon catheters
    • A61M25/1029Production methods of the balloon members, e.g. blow-moulding, extruding, deposition or by wrapping a plurality of layers of balloon material around a mandril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1002Balloon catheters characterised by balloon shape
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1334Nonself-supporting tubular film or bag [e.g., pouch, envelope, packet, etc.]
    • Y10T428/1345Single layer [continuous layer]

Definitions

  • This invention relates to the manufacturing of balloons for use with therapeutic medical balloon catheters.
  • Balloon catheters are used in many medical procedures such as ablation, drug delivery, brachytherapy, chemotherapy, coronary angioplasty and thromboembolectomy. Regardless of whether the use to which the balloon catheter is being put involves transmitting substances, as in the case of chemotherapy or brachytherapy, or transmitting energy, as in the case of ablation, to a target site, it is preferred that the transmitting surface of the balloon be maintained in close contact with the target surface. At present, this most often involves careful application and control of pressure to the balloon by the operator from a location quite remote from the balloon. This generally requires substantial skill and, depending on the length of the procedure being applied, can be quite exhausting.
  • a therapeutic payload (the most notable exception being coronary angioplasty wherein the expansion of the balloon itself elicits the desired therapeutic effect), be it radiation, a drug, cold, RF energy, etc., to the target site.
  • RF energy must be delivered from its source, usually outside the patient's body, to specific locations on the balloon that is situated at the target site.
  • Means for achieving this include having thin conductive metal electrodes displayed in a desired pattern on the outer surface of the balloon and using the patient's body as the second electrode or ground.
  • the balloon itself may be rendered energy-transmissive by doping the material from which it is made with a conductive metal or other conducive substance. A non-conductive mask is then applied to a surface of the conductive balloon to create the desired ablation pattern.
  • ablation balloons Numerous other ways of creating ablation balloons are known in the art. All of them are generally relatively complicated to manufacture and tend to be quite expensive.
  • a balloon catheter comprises a distally- located inflatable balloon comprising an energy-conductive hydrophilic polymer having a tensile strength of at least 3000 psi, wherein the balloon is molded to inflate to specified equilibrium dimensions when subjected to about one atmosphere of internal pressure.
  • the hydrophilic polymer preferably has an elasticity that permits the balloon to inflate to dimensions greater than its equilibrium dimensions under more than one atmosphere of internal pressure without failing.
  • the balloon can be inflated to dimensions at least 50% greater than its equilibrium dimensions.
  • the hydrophilic polymer when hydrated, comprises from 10 volume percent to about 40 volume percent water.
  • the hydrophilic polymer, when hydrated may comprise about 20% volume percent water.
  • the hydrophilic polymer may comprise a conductive homopolymeric or co- polymeric thermoplastic polyurethane when hydrated with an electrolytic solution.
  • the balloon may further comprise a non-conductive polymer mask adhered to a surface of the balloon to create a pattern of conductive and non-conductive areas wherein the non-conductive polymer has physical and chemical characteristics compatible with those of the hydrophilic polymer.
  • the non-conductive polymer may comprise a non-conductive homopolymeric or co-polymeric thermoplastic polyurethane.
  • the conductive areas of the balloon have a wall thickness of from about 0.0005" to about 0.005".
  • a balloon catheter in another embodiment, includes a balloon that, when inflated under about one atmosphere of pressure or over-inflated with greater than one atmosphere of pressure, comprises a generally elongate member having a proximal end, a distal end, a first diameter at or near the proximal end, a second diameter at or near the distal end and a third diameter located between the first and second diameters, wherein the first and second diameters may be the same or different , the third diameter is less than both the first and second diameters; the first diameter is coupled to the third diameter by a distal-facing sloping surface; and, the second diameter is coupled to the third diameter by a proximal-facing sloping surface.
  • the second diameter is less than the first diameter.
  • the distal-facing sloping surface comprises a therapeutic element.
  • the therapeutic element may be selected from the group consisting of an RF energy transmitting element, a microwave energy transmitting element, an ultrasound energy transmitting element, a laser light energy transmitting element, a drug delivery element, a radiation energy delivery element, a cryogenic energy transmitting element and a cutting element.
  • the balloon comprises a an energy-conductive hydrophilic polymer having a tensile strength of at least 3000 psi.
  • the hydrophilic polymer, when hydrated comprises from 10 volume percent to about 40 volume percent water. In one embodiment, the hydrophilic polymer, when hydrated, comprises about 20% volume percent water.
  • the hydrophilic polymer comprises a conductive homopolymeric or co-polymeric thermoplastic polyurethane (e.g., TECOPHILIC ® ) when hydrated with an electrolytic solution.
  • the balloon further comprises a non-conductive polymer mask adhered to its distal-facing surface to create a pattern of conductive and non- conductive areas wherein the non-conductive polymer has physical characteristics compatible with those of the hydrophilic polymer.
  • the non-conductive polymer may be NeoRez 967 ® , a non-conductive homopolymeric or co-polymeric thermoplastic polyurethane, or TECOFLEX ® .
  • an electrode assembly comprises an elongate member.
  • An inflatable member is secured to the elongate member, the inflatable member having a proximal end, a distal end, a lumen extending therebetween, and a conductive region.
  • An electrode is carried by the elongate member, the electrode located within the lumen of the inflatable member and proximal to the conductive region of the inflatable member.
  • the inflatable member may comprise an energy-conductive hydrophilic polymer having a tensile strength of at least 3000 psi.
  • the inflatable member is molded to inflate to specified equilibrium dimensions when subjected to about one atmosphere of internal pressure.
  • the electrode assembly further comprises a non- conductive polymer mask adhered to a surface of the inflatable member to create a pattern of non-conductive area wherein the non-conductive polymer has physical and chemical characteristics compatible with those of the hydrophilic polymer.
  • Figure 1 is a schematic representation of a balloon catheter.
  • Fig. 1 A shows the overall catheter and
  • Fig. 1 B shows a deployed balloon.
  • Figure 2 is a schematic representation of a balloon of this invention shown in the form of an ablation balloon.
  • the depiction of an ablation balloon, while one embodiment of this invention, is not the only use to which the balloons herein can be put. That is, the depiction is for illustrative purposes only and is not intended, nor should it be construed as limiting the scope of this invention.
  • Figure 3 is a schematic representation of a self-anchoring balloon of this invention.
  • FIG. 4 is a schematic representation of an ablation system, which includes a balloon in accordance with an embodiment of this invention.
  • the depiction of an ablation balloon, while one embodiment of this invention, is not the only use to which the balloons herein can be put. That is, the depiction is for illustrative purposes only and is not intended, nor should it be construed as limiting the scope of this invention.
  • Figure 5 illustrates a side cross sectional view of an electrode assembly, which includes a balloon in accordance with an embodiment of this invention.
  • catheter shaft 9 has a distal section 12 which contains deployable balloon 10, a shaft distal end 2 a shaft proximal end 3 and at least one lumen 13 extending between the two ends.
  • Lumen 13 has at least one opening at the distal section 12 of the catheter shaft 9.
  • Handle 4 is located at the proximal end of catheter shaft 9. The handle may contain means for controlling the movement of distal section 12 of shaft 9.
  • Handle 4 may also include one or more hollow tubes 7, each having a proximal end, a distal end, a passageway and a locking valve 8 attached to it.
  • Each such passageway is connected to one of the lumens 13 and is used to deliver and receive substances, in particular a working fluid for the inflation of the balloon when deployed, to and from distal section 12.
  • a balloon catheter has at least two lumens 13, one for inflation of the balloon and one for deflation of the balloon.
  • additional passageways and/or lumens are required for passage of wires from an RF generator, usually located remote from the catheter and connected thereto by electrical wires, to electrodes located at balloon 10.
  • FIG. 1B shows a balloon deployed and inflated.
  • Balloon 10 is shown with a conductive region 14 and a non-conductive region 17, as would be the case when the balloon catheter is used for ablation.
  • the working fluid used o inflate the balloon is usually physiological saline, which is conductive and compatible with body fluids.
  • a ground electrode is attached to a remote location the patient's body, conductive region 14 is placed in contact with tissue to be ablated and RF energy is transmitted to the saline by wire/electrode 20 which is attached to an energy source at its other end, and then through the conducive region to the tissue.
  • the balloon of the balloon catheter is constructed of a polymeric substance that is hydrophilic.
  • hydrophilic is meant that the polymer, when in contact with an aqueous solution, can absorb a quantity of water into it's structure while still maintaining its structural integrity. When the polymer absorbs water, it is said to be hydrated.
  • the hydrophilic polymer must have sufficient strength to maintain structural integrity even when the balloon is subjected to substantial internal pressure as from a working fluid, usually physiological saline, used to inflate it and to external forces such as abrasion that might occur on contact with the interior surfaces of a patient's vessels.
  • a working fluid usually physiological saline
  • the hydrophilic polymer must have an ultimate tensile strength, both dry and in the hydrated state, of at least 3000 psi.
  • tensile strength has its usual meaning, that is, the force, measured in pounds per square inch (psi) needed to stretch the polymer until it breaks.
  • Balloons of this invention can be constructed by any of the various techniques well-known to those skilled in the art.
  • the polymer can be dip-coated on a mandrel that has a defined size and shape.
  • the balloon When removed from the mandrel, the balloon, when inflated with about one atmosphere of pressure will assume the dimensions of the mandrel without incurring any tensional force in the polymer.
  • This condition, the shape and dimensions of a balloon inflated with about one atmosphere pressure after formation by whatever means selected will, for the purpose of this discussion, be called the balloon's equilibrium dimensions.
  • Balloon may also be formed by spin-coating in a hollow mold.
  • balloons can be formed by injection or blow molding. In this process, a pre-formed length of tubing made of the polymer is placed in a hollow mold having internal dimensions that reflect the desired equilibrium dimensions of the balloon to be formed. One end of the tube is sealed off and a working fluid is injected into the open end of the tube with sufficient force to cause the working fluid to expand the tubing until the wall of the tubing is in intimate contact with the inner surface of the mold.
  • the polymer is then annealed, if desired, and cooled after which the mold is removed leaving a portion of the tubing as a balloon that, upon inflation, will assume equilibrium dimensions.
  • the above are but a few exemplary methods of forming balloons according to embodiments of the invention. Others will be apparent to those skilled in the art based on the disclosures herein. All such methods are within the scope of this invention.
  • the polymeric material of which a balloon is made had sufficient elasticity so as to be capable of stretching substantially beyond its equilibrium dimensions without failing, that is tearing or bursting, when subjected to internal pressures greater than one atmosphere.
  • elasticity is a measure of the ability of a material to stretch under tension to beyond its initial dimensions and then to return to, or nearly to, its original dimensions when the tension is relaxed.
  • polymers used to make balloon of this invention may react in the classical manner and, as such, are within the scope of this invention, such is not necessarily the case. That is, a balloon of this invention may be capable of inflation up to 400% of its equilibrium dimensions but may not return to, or even nearly to, its equilibrium dimensions when deflated and may in fact remain substantially "stretched out.” It is preferred that the hydrophilic polymer selected for balloons of this invention be such that the balloon is capable, when hydrated, of up to 50% expansion beyond its equilibrium dimensions.
  • a balloon of this invention When being inflated, a balloon of this invention will expand in such a manner that all its dimensions increase in approximately a constant ratio to the corresponding equilibrium dimension; that is, as it is inflated the balloon essentially retains its initial equilibrium shape - it just gets bigger.
  • One hydrophilic polymer from which to make balloons of this invention is TECOPHILIC ® , manufactured by Thermedics Polymer Products, Woburn, MA.
  • TECOPHILIC ® is a polyether-based aliphatic polyurethane.
  • the TECOPHILIC ® family of polyurethanes meet all the criteria discussed above for balloon of this invention.
  • TECOPHILIC ® HP-60D-35 a member of the family from which to manufacture balloons of this invention, has an ultimate tensile strength (pressure required to break apart a sample of polymer) of 7800 psi dry and 4900 hydrated. In addition, it has an ultimate elongation, i.e., elongation to break which is related to elasticity as used herein, of 450% dry and 390% hydrated.
  • elongation to break which is related to elasticity as used herein, of 450% dry and 390% hydrated.
  • Other hydrophilic polymers having the desired physical characteristics will become apparent to those skilled in the art based on the disclosures herein and are within the scope of this invention.
  • the TECOPHILIC ® balloon is rendered conductive by hydration with an electrolytic solution, that is, a solution containing sufficient ionic content to conduct energy such as RF energy.
  • the electrolytic solution is normally physiological saline, that is, a sterile approximately 0.9% aqueous sodium chloride solution that is isotonic with body fluids.
  • Any salt solution at any desired concentration can, however, be used although it is preferred that the salt be one that is not detrimental to tissue or the health of the patient in the unlikely event that a balloon should inadvertently rupture.
  • a balloon of this invention is intended for use in an ablation balloon catheter.
  • a non-conductive mask is applied to a surface of the conductive hydrophilic balloon to create a pattern for ablation.
  • a masked balloon is shown in Fig. 2.
  • Balloon 105 has distal-facing surface 112 and proximal- facing suface 111.
  • Proximal catheter shaft 100 protrudes from the proximal end of balloon 105 while catheter tip 101 protrudes from the distal end of balloon 105.
  • the non-cross-hatched portions 1 10 of the surface of balloon 105 are non-conductive by virtue of a mask adhered to a surface of the balloon.
  • the mask may be adhered to the outer or inner surface of the balloon.
  • Cross-hatched portion 120 of the surface of balloon 105 is the conductive region.
  • region 120 When the distal end of balloon 105 is inserted in a vessel such as the pulmonary vein of a patient from within the heart, region 120 is pressed up against the heart wall at the ostium or opening from the heart into the vein.
  • a ground electrode is attached to a remote location on the patients body and then an RF signal is generated at the proximal end of the catheter proximal to section 100 of the catheter shaft (usually at a generator attached to the catheter in the vicinity of the handle) and is transmitted through wire 131 to electrode 130.
  • the signal is conducted through region 120 of the balloon and a circuit is completed so that RF energy is delivered to the tissue in contact with region 120 and is thereby ablated.
  • the non- conductive polymer used to create the mask must have physical characteristics compatible with those of the hydrophilic polymer used to form the balloon. That is, at the very least, the non-conductive polymer must have a tensile strength and elasticity at least equivalent to that of the hydrophilic polymer so that the non- conductive polymer does not prematurely break when the balloon is inflated thus disrupting the desired ablation pattern. It is also necessary that the non-conductive polymer have chemical characteristics compatible with those of the hydrophilic polymer, at least insofar as is necessary to achieve sufficient adhesion of the non- conductive mask to the surface of the hydrophilic polymer balloon both in the dry and hydrated state.
  • Sufficient adhesion means that the mask will remain in place and will not separate from the surface of the balloon either when the balloon is deflated, folded and stored in the catheter or when the balloon is deployed, hydrated and inflated.
  • a wide range of non-conductive polymers can be used to create masks compatible with a TECOPHILIC ® balloon.
  • a preferred mask polymer is TECOFLEX ® SG-85A, also manufactured by Thermedics Polymer Products.
  • TECOFLEX ® like TECOPHILIC ® , is a polyether-based aliphatic polyurethane and therefore is very compatible with TECOPHILIC ® chemically so that masks formed from TECOFLEX ® adhere well to surfaces made of TECOPHILIC ® .
  • the TECOFLEX has an ultimate tensile strength and elongation that is compatible with the TECOPHILIC.
  • Other matching TECOFLEX ® and TECOPHILIC ® family member useful for making the balloons of this invention will become apparent to those skilled in the art based on the disclosure herein and are within the scope of this invention.
  • the masking polymers are preferably those that can be coated from an aqueous medium so as to avoid contacting the TECOPHILIC ® with a solvent that might affect its integrity.
  • a non-conductive masking polymer is NeoRez 967 ® from NeoResins, Wilmington Delaware.
  • aqueous medium polymers may also be used with TECOPHILIC ® balloons made by any method, not just blow-molded balloons so that, for example without limitation, NeoRez 967 ® could be substituted for TECOFLEX ® in the above-described dip- coated balloon.
  • the surface of the TECOPHIIC ® balloon can be pre-treated to assist in prevention of bead formation during film formation and to enhance adhesion and coating uniformity.
  • the surface of the TECOPHILIC ® balloon can be subjected to an Argon plasma prior to coating.
  • other hydrophilic polymers that can be rendered conductive by hydration with electrolytic solutions and that have the requisite physical characteristics
  • a "therapeutic element” simply refers to the features of that portion of a balloon that permits the desired therapy to be administered.
  • the therapeutic element is the conductive portion of the balloon that is in contact with the tissue to be ablated.
  • that portion of the balloon that is in contact with the patient's tissue must be permeable to the drug.
  • the portion of the balloon that is in contact with the tissue to be treated must be capable of retaining the radioactive material on its surface and then controllably depositing it at the target site.
  • a means for self-anchoring of the balloon in the correct orientation would be highly desirable. This can be accomplished using the essentially hourglass-shaped balloon of this invention shown in Fig. 3.
  • balloon 300 is shown inflated in the locus of the ostium 310 of a vessel 320 in a patient's body.
  • Balloon 300 consists of a first diameter 302, a second diameter 304 and a third diameter 306. Diameter 306 is smaller than either diameter 302 or diameter 304.
  • Diameters 302 and 304 can be the same or different. In one embodiment, diameter 304 is less than diameter 302 (and diameter 306 is less than either of the other two).
  • the catheter shaft 330, having distal end 335 and proximal end 337 is inserted into the vessel prior to inflation of the balloon. As the balloon inflates, the segment having diameter 302 expands and presses against wall 322 of vessel 320, causing it to dilate.
  • the tissue 380 at the proximal side of the ostium is, in most circumstances, thicker than and therefore less elastic than the tissue of the wall 322 of the vessel.
  • the pressure of proximal-facing sloped surface 340 against wall 322 pulls distal- facing sloped surface 350 into intimate contact with tissue 380 in the vicinity of the ostium and holds it there thus relieving the operator of the chore of manually maintaining pressure on the balloon.
  • This is at times referred to herein as self- anchoring of the balloon.
  • the balloon is shown as an ablation balloon. That is, the distal-facing sloped surface 350 is shown as having an energy- conductive band 380 that contacts tissue around the ostium. The remainer of the balloon is masked by a non-conductive polymer.
  • FIG. 4 shows a tissue ablation system 400, which includes a balloon constructed in accordance with an embodiment of the invention.
  • the system 400 includes an ablation catheter 410, a generator 420 for delivering energy to the catheter 410 to ablate tissue, an indifference electrode 430 (e.g., an electrode pad) coupled to the generator 420, and a source 432 of fluid coupled to the catheter 410.
  • the catheter 410 comprises a handle assembly 440, a guide tube assembly 442, and an electrode assembly 444 having an inflatable balloon 710.
  • the guide tube assembly 442 delivers electrically conductive fluid from the fluid source 432 to inflate the balloon 710 at the electrode assembly 444.
  • the generator 420 is coupled to the handle assembly 440 of the catheter 410 via a cable 446, so that radio frequency (RF) energy can be delivered to the electrode assembly 444.
  • RF radio frequency
  • the system 400 operates in a unipolar mode.
  • the indifference electrode 430 is attached to a patient's back or other exterior skin area, and ablation energy will flow from the electrode assembly 444 to the patch electrode 430.
  • the system 400 can be operated in a bipolar mode, in which case, the system 400 does not include the indifference electrode 430, and ablation energy will flow from one electrode on the electrode assembly 444 to an adjacent electrode (not shown) on the electrode assembly 444 or on the guide tube assembly 442.
  • the guide tube assembly 442 includes an inner shaft 450 having a distal end
  • the shaft 450 also includes an inflation port 728 and a deflation port 730 located along the shaft 450, and a distal opening 732 at the distal tip of the shaft 450.
  • the shaft 450 includes four lumens 456a-456d. Lumen 456a, which is in fluid communication with the inflation port 728, is used to deliver fluid from the fluid source 432 to the electrode assembly 444 for inflation of the balloon 710.
  • Lumen 456b which is in fluid communication with the deflation port 730, is used to transport delivered fluid from the electrode assembly 444 back to the fluid source 432 or to another container for disposal of the fluid as the balloon 710 is deflated.
  • Lumen 456c extends to the distal tip opening 732, and can be used to house a guidewire (not shown) that is inserted into the opening 732, through the shaft 450, and out of a port 441 located on the handle assembly 440.
  • Lumen 456d is used to house wire(s) (e.g., RF lead wires and thermistor wires) that connect an electrically activated element at the electrode assembly 444 to the generator 420.
  • the size and shape of the lumens 456 should not be limited to the example illustrated in the figure, and that the lumens 456 can have sizes and shapes that are different from that shown.
  • the functionalities of the lumens 456 can vary.
  • lumen 456c can be used to deliver radiopaque contrast to a target site.
  • the inner shaft 450 comprises a lower durometer Pebax braided shaft.
  • the inner shaft 450 can also be made from a variety of materials, such as polymer, plastics, a thermoplastic material (e.g., plyurethane, polyolefin or polyetherpolyamide block copolymer). As shown in FIGS.
  • the guide tube assembly 442 also includes an outer shaft 480 coaxially surrounding the inner shaft 450 to strengthen and/or to improve a durability of the guide tube assembly 442, and an outer sheathing 490 secured to an outer surface of the outer shaft 480 for enhancing a stiffness of the guide tube assembly 442.
  • Materials suitable for construction of the inner shaft 450 can also be used for the outer shaft 480.
  • the diameter or the cross sectional dimension of the outer shaft 480 is preferably about 5.5 French (F).
  • the outer shaft 480 can also have other cross sectional dimensions.
  • the sheathing 490 can include, for example, a stainless steel coiled into a flexible spring, and a sheath of extruded plastic material containing wire braids enclosing the spring.
  • the electrode assembly 444 includes an electrode 700 secured to the guide tube assembly 442, and a balloon 710.
  • the balloon 710 has a distal end 712 and a proximal end 714 secured to the guide tube assembly 442.
  • the balloon 710 also has a conductive region 716 located between the distal and proximal ends 712, 714.
  • the electrode 700 is a coil having a lumen that extends between the ends of the coil. Ablation wires (not shown) connect the electrode 700 to the generator 420, and are housed in one of the lumens 456 of the shaft 450.
  • the electrode 700 is secured to the shaft 450 by a suitable adhesive at both ends of the electrode 700.
  • the electrode 700 can be secured to the shaft 450 at other locations of the electrode 700.
  • Using a coil for construction of the electrode 700 is advantageous in that it allows the shaft 450 to easily deflect or bend as the shaft 450 is delivered over a guidewire.
  • the coil electrode 700 also provides a large electrode surface to improve heat dissipation and lower impedance during use.
  • the shaft 450 has a section 720 with a diameter or cross sectional dimension that is less than that of an adjacent section of the shaft 450, such that when the electrode coil 700 is placed around the section 720, the electrode 700 will substantially flush with an exterior surface of the outer shaft 480 to form a smooth surface.
  • Such configuration reduces the overall profile of the electrode assembly 444, and reduces the risk of the electrode 700 abrading the balloon 710 during use.
  • the electrode 700 is positioned proximal to the conductive region 716 of the balloon 710.
  • Such configuration prevents the electrode 700 from abrading the conductive region 716 of the balloon 710 during use (e.g., while inserting the balloon 710 into a delivery or access tube), and allows the electrode assembly 444 to form more uniform lesions without excessive charring.
  • the electrode 700 can be placed distal to the conductive region 716, or at the same axial location along an axis 760 of the inner shaft 750. It should be noted that the configurations of the electrode 700 and the balloon 710 are not limited to those shown in the figure.
  • the electrode 700 can have a shape of a ring, a tubular segment, or other shapes, and the balloon 710 can have other shapes, such as a spherical shape, an elliptical shape, or a dumbbell shape.
  • the distal end 452 of the shaft 450 does not penetrate through the balloon 710.
  • the balloon 710 has a closed distal end 712, and the electrode 700 is secured to the distal end 452 of the shaft 450, which is disposed within a lumen 734 of the balloon 710.
  • the distal end 452 of the shaft 500 has one or more openings that are in fluid communication with the one or more lumens 456 of the shaft 450 for delivering and draining fluid to and from the lumen 734 of the balloon 710.
  • the distal end 452 of the shaft 450 has a closed tip, in which case, the shaft 450 has one or more openings 728 along its length for delivering and draining inflation fluid to and from the balloon 710, as similarly discussed previously.
  • the electrode 700 can be secured to a distal end of an elongate structure, such as a pusher, which is slidably disposed within one of the lumens 456 of the shaft 450.
  • the electrode assembly 444 also includes a sensor 790, such as a thermistor, secured to the inner shaft 450.
  • the outer shaft 480 has an opening 792 and the inner shaft 450 has a recess 794 for accommodating the sensor 790.
  • the recess 794 has a depth such that when the sensor 790 is attached to the inner shaft 450, the sensor 790 lies substantially flush with an exterior surface of the outer shaft 480.
  • the sensor 790 is not necessarily limited to a thermistor, and that the sensor 790 can be a variety of sensing devices, such as an impedance sensor or a current sensor.
  • a method of using the system 400 will now be described with reference to cardiac ablation therapy.
  • a physician inserts a guidewire through a main vein or artery (typically the femoral vein or artery) of a patient into an interior region of a heart that is to be treated.
  • the physician then inserts a proximal end of the guidewire into the distal opening 732 of the inner shaft 750, and distally advances the electrode assembly 444 over the guidewire until the electrode assembly 444 reaches a treatment site.
  • an access shaft or tube can be provided and inserted over the guidewire. In such case, the electrode assembly 444 can be placed in the access shaft and distally advanced to reach the treatment site.
  • the electrode assembly 444 can be placed within the access shaft first, and the electrode assembly 444 together with the access shaft are then delivered over the guidewire, and advanced to the treatment site.
  • the catheter 410 can include a steering mechanism for steering a distal end of the catheter 410. In such case, the use of the guidewire and/or the access shaft may not be required, and the physician can place the electrode assembly 444 into contact with a tissue within the heart that is targeted for ablation by operating the steering mechanism.
  • inflation fluid such as an electrically conductive fluid, is then delivered from the fluid source 432 to the electrode assembly 444. Particularly, the fluid exits through inflation port 728 to inflate the balloon 710.
  • Energy is then directed from the generator 420 to the electrode 700, and energy will flow from the electrode 700 to the conductive region 716 via the delivered conductive fluid to ablate the tissue and form a lesion on the tissue.
  • the delivered fluid can be drained from the lumen 734 of the balloon 710 to deflate the balloon 710, and the catheter 410 can be removed from the patient.

Abstract

Medical balloon catheters wherein the balloons are constructed of hydrophilic energy conductive polymers. The catheter balloons may self-anchor at a target site in a patient's body, and may have very small cross-sectional profiles at the distal end.

Description

CATHETER BALLOONS COMPRISING AN ENERGY-CONDUCTIVE HYDROPHILIC POLYMER
This invention relates to the manufacturing of balloons for use with therapeutic medical balloon catheters.
BACKGROUND OF THE INVENTION
Balloon catheters are used in many medical procedures such as ablation, drug delivery, brachytherapy, chemotherapy, coronary angioplasty and thromboembolectomy. Regardless of whether the use to which the balloon catheter is being put involves transmitting substances, as in the case of chemotherapy or brachytherapy, or transmitting energy, as in the case of ablation, to a target site, it is preferred that the transmitting surface of the balloon be maintained in close contact with the target surface. At present, this most often involves careful application and control of pressure to the balloon by the operator from a location quite remote from the balloon. This generally requires substantial skill and, depending on the length of the procedure being applied, can be quite exhausting. Most balloon catheter uses require means for delivering a therapeutic payload (the most notable exception being coronary angioplasty wherein the expansion of the balloon itself elicits the desired therapeutic effect), be it radiation, a drug, cold, RF energy, etc., to the target site. For example, to ablate an area of a vessel in a patient's body, RF energy must be delivered from its source, usually outside the patient's body, to specific locations on the balloon that is situated at the target site. Means for achieving this include having thin conductive metal electrodes displayed in a desired pattern on the outer surface of the balloon and using the patient's body as the second electrode or ground. Alternatively, the balloon itself may be rendered energy-transmissive by doping the material from which it is made with a conductive metal or other conducive substance. A non-conductive mask is then applied to a surface of the conductive balloon to create the desired ablation pattern. Numerous other ways of creating ablation balloons are known in the art. All of them are generally relatively complicated to manufacture and tend to be quite expensive. SUMMARY OF THE INVENTION
In one embodiment of this invention a balloon catheter comprises a distally- located inflatable balloon comprising an energy-conductive hydrophilic polymer having a tensile strength of at least 3000 psi, wherein the balloon is molded to inflate to specified equilibrium dimensions when subjected to about one atmosphere of internal pressure. The hydrophilic polymer preferably has an elasticity that permits the balloon to inflate to dimensions greater than its equilibrium dimensions under more than one atmosphere of internal pressure without failing. In another embodiment, the balloon can be inflated to dimensions at least 50% greater than its equilibrium dimensions. In one embodiment, the hydrophilic polymer, when hydrated, comprises from 10 volume percent to about 40 volume percent water. For example, the hydrophilic polymer, when hydrated, may comprise about 20% volume percent water. The hydrophilic polymer may comprise a conductive homopolymeric or co- polymeric thermoplastic polyurethane when hydrated with an electrolytic solution. The balloon may further comprise a non-conductive polymer mask adhered to a surface of the balloon to create a pattern of conductive and non-conductive areas wherein the non-conductive polymer has physical and chemical characteristics compatible with those of the hydrophilic polymer. For example, the non-conductive polymer may comprise a non-conductive homopolymeric or co-polymeric thermoplastic polyurethane. The conductive areas of the balloon have a wall thickness of from about 0.0005" to about 0.005". In another embodiment of this invention, a balloon catheter includes a balloon that, when inflated under about one atmosphere of pressure or over-inflated with greater than one atmosphere of pressure, comprises a generally elongate member having a proximal end, a distal end, a first diameter at or near the proximal end, a second diameter at or near the distal end and a third diameter located between the first and second diameters, wherein the first and second diameters may be the same or different , the third diameter is less than both the first and second diameters; the first diameter is coupled to the third diameter by a distal-facing sloping surface; and, the second diameter is coupled to the third diameter by a proximal-facing sloping surface. In one embodiment, the second diameter is less than the first diameter. In one embodiment, the distal-facing sloping surface comprises a therapeutic element. For example, the therapeutic element may be selected from the group consisting of an RF energy transmitting element, a microwave energy transmitting element, an ultrasound energy transmitting element, a laser light energy transmitting element, a drug delivery element, a radiation energy delivery element, a cryogenic energy transmitting element and a cutting element. In one embodiment, the balloon comprises a an energy-conductive hydrophilic polymer having a tensile strength of at least 3000 psi. For example, the hydrophilic polymer, when hydrated, comprises from 10 volume percent to about 40 volume percent water. In one embodiment, the hydrophilic polymer, when hydrated, comprises about 20% volume percent water. In one embodiment, the hydrophilic polymer comprises a conductive homopolymeric or co-polymeric thermoplastic polyurethane (e.g., TECOPHILIC®) when hydrated with an electrolytic solution. In one embodiment, the balloon further comprises a non-conductive polymer mask adhered to its distal-facing surface to create a pattern of conductive and non- conductive areas wherein the non-conductive polymer has physical characteristics compatible with those of the hydrophilic polymer. By way of non-limiting examples, the non-conductive polymer may be NeoRez 967®, a non-conductive homopolymeric or co-polymeric thermoplastic polyurethane, or TECOFLEX®. The conductive areas of the balloon preferably have a wall thickness of from about 0.0005" to about 0.005". The balloon catheter may comprise an ablation balloon catheter, e.g., using RF energy. In yet another embodiment, an electrode assembly comprises an elongate member. An inflatable member is secured to the elongate member, the inflatable member having a proximal end, a distal end, a lumen extending therebetween, and a conductive region. An electrode is carried by the elongate member, the electrode located within the lumen of the inflatable member and proximal to the conductive region of the inflatable member. The inflatable member may comprise an energy-conductive hydrophilic polymer having a tensile strength of at least 3000 psi. In one embodiment, the inflatable member is molded to inflate to specified equilibrium dimensions when subjected to about one atmosphere of internal pressure. In one embodiment, the electrode assembly further comprises a non- conductive polymer mask adhered to a surface of the inflatable member to create a pattern of non-conductive area wherein the non-conductive polymer has physical and chemical characteristics compatible with those of the hydrophilic polymer.
BRIEF DESCRIPTION OF THE DRAWING Figure 1 is a schematic representation of a balloon catheter. Fig. 1 A shows the overall catheter and Fig. 1 B shows a deployed balloon. Figure 2 is a schematic representation of a balloon of this invention shown in the form of an ablation balloon. The depiction of an ablation balloon, while one embodiment of this invention, is not the only use to which the balloons herein can be put. That is, the depiction is for illustrative purposes only and is not intended, nor should it be construed as limiting the scope of this invention. Figure 3 is a schematic representation of a self-anchoring balloon of this invention. Again, the balloon is shown as an ablation balloon but this is for illustrative purposes only and likewise is not intended, nor is it to be construed as limiting the scope of this invention in any manner whatsoever. Figure 4 is a schematic representation of an ablation system, which includes a balloon in accordance with an embodiment of this invention. The depiction of an ablation balloon, while one embodiment of this invention, is not the only use to which the balloons herein can be put. That is, the depiction is for illustrative purposes only and is not intended, nor should it be construed as limiting the scope of this invention. Figure 5 illustrates a side cross sectional view of an electrode assembly, which includes a balloon in accordance with an embodiment of this invention.
DETAILED DESCRIPTION OF THE ILLUSTRATED EMBODIMENTS The balloons of embodiments of this invention may be used with any balloon catheter of any design. A balloon catheter is shown generically in Fig. 1. It is understood that nothing in the figure is intended, nor is to be construed, to limit the scope of this invention in any manner whatsoever. In Fig. 1A, catheter shaft 9 has a distal section 12 which contains deployable balloon 10, a shaft distal end 2 a shaft proximal end 3 and at least one lumen 13 extending between the two ends. Lumen 13 has at least one opening at the distal section 12 of the catheter shaft 9. Handle 4 is located at the proximal end of catheter shaft 9. The handle may contain means for controlling the movement of distal section 12 of shaft 9. Handle 4 may also include one or more hollow tubes 7, each having a proximal end, a distal end, a passageway and a locking valve 8 attached to it. Each such passageway is connected to one of the lumens 13 and is used to deliver and receive substances, in particular a working fluid for the inflation of the balloon when deployed, to and from distal section 12. In general, a balloon catheter has at least two lumens 13, one for inflation of the balloon and one for deflation of the balloon. In the case of an ablation balloon catheter, additional passageways and/or lumens are required for passage of wires from an RF generator, usually located remote from the catheter and connected thereto by electrical wires, to electrodes located at balloon 10. At the distal end of section 12 is a guide wire lumen 19 through which guide wire 18 is passed. Figure 1B shows a balloon deployed and inflated. Balloon 10 is shown with a conductive region 14 and a non-conductive region 17, as would be the case when the balloon catheter is used for ablation. In this case, the working fluid used o inflate the balloon is usually physiological saline, which is conductive and compatible with body fluids. A ground electrode is attached to a remote location the patient's body, conductive region 14 is placed in contact with tissue to be ablated and RF energy is transmitted to the saline by wire/electrode 20 which is attached to an energy source at its other end, and then through the conducive region to the tissue. It is understood that depiction of the balloon as an ablation device is for illustrative purposes only and is not intended, nor is it to be construed, as limiting the invention in any way. In one aspect of this invention, the balloon of the balloon catheter is constructed of a polymeric substance that is hydrophilic. By hydrophilic is meant that the polymer, when in contact with an aqueous solution, can absorb a quantity of water into it's structure while still maintaining its structural integrity. When the polymer absorbs water, it is said to be hydrated. To be useful as a balloon-forming material of this invention, the hydrophilic polymer must have sufficient strength to maintain structural integrity even when the balloon is subjected to substantial internal pressure as from a working fluid, usually physiological saline, used to inflate it and to external forces such as abrasion that might occur on contact with the interior surfaces of a patient's vessels. Thus, in one embodiment, the hydrophilic polymer must have an ultimate tensile strength, both dry and in the hydrated state, of at least 3000 psi. As used herein, tensile strength has its usual meaning, that is, the force, measured in pounds per square inch (psi) needed to stretch the polymer until it breaks. Balloons of this invention can be constructed by any of the various techniques well-known to those skilled in the art. For example without limitation, the polymer can be dip-coated on a mandrel that has a defined size and shape. When removed from the mandrel, the balloon, when inflated with about one atmosphere of pressure will assume the dimensions of the mandrel without incurring any tensional force in the polymer. This condition, the shape and dimensions of a balloon inflated with about one atmosphere pressure after formation by whatever means selected will, for the purpose of this discussion, be called the balloon's equilibrium dimensions. Balloon may also be formed by spin-coating in a hollow mold. When the mold is removed, as in the case of a dip-coated mandrel, the balloon will inflate to equilibrium dimensions that are the same as the interior dimensions of the hollow mold. In addition, balloons can be formed by injection or blow molding. In this process, a pre-formed length of tubing made of the polymer is placed in a hollow mold having internal dimensions that reflect the desired equilibrium dimensions of the balloon to be formed. One end of the tube is sealed off and a working fluid is injected into the open end of the tube with sufficient force to cause the working fluid to expand the tubing until the wall of the tubing is in intimate contact with the inner surface of the mold. The polymer is then annealed, if desired, and cooled after which the mold is removed leaving a portion of the tubing as a balloon that, upon inflation, will assume equilibrium dimensions. The above are but a few exemplary methods of forming balloons according to embodiments of the invention. Others will be apparent to those skilled in the art based on the disclosures herein. All such methods are within the scope of this invention. In addition to tensile strength, in one embodiment, the polymeric material of which a balloon is made had sufficient elasticity so as to be capable of stretching substantially beyond its equilibrium dimensions without failing, that is tearing or bursting, when subjected to internal pressures greater than one atmosphere. Classically, elasticity is a measure of the ability of a material to stretch under tension to beyond its initial dimensions and then to return to, or nearly to, its original dimensions when the tension is relaxed. While the polymers used to make balloon of this invention may react in the classical manner and, as such, are within the scope of this invention, such is not necessarily the case. That is, a balloon of this invention may be capable of inflation up to 400% of its equilibrium dimensions but may not return to, or even nearly to, its equilibrium dimensions when deflated and may in fact remain substantially "stretched out." It is preferred that the hydrophilic polymer selected for balloons of this invention be such that the balloon is capable, when hydrated, of up to 50% expansion beyond its equilibrium dimensions. When being inflated, a balloon of this invention will expand in such a manner that all its dimensions increase in approximately a constant ratio to the corresponding equilibrium dimension; that is, as it is inflated the balloon essentially retains its initial equilibrium shape - it just gets bigger. One hydrophilic polymer from which to make balloons of this invention is TECOPHILIC®, manufactured by Thermedics Polymer Products, Woburn, MA. TECOPHILIC® is a polyether-based aliphatic polyurethane. The TECOPHILIC® family of polyurethanes meet all the criteria discussed above for balloon of this invention. That is, TECOPHILIC® HP-60D-35, a member of the family from which to manufacture balloons of this invention, has an ultimate tensile strength (pressure required to break apart a sample of polymer) of 7800 psi dry and 4900 hydrated. In addition, it has an ultimate elongation, i.e., elongation to break which is related to elasticity as used herein, of 450% dry and 390% hydrated. Other hydrophilic polymers having the desired physical characteristics will become apparent to those skilled in the art based on the disclosures herein and are within the scope of this invention. The TECOPHILIC® balloon is rendered conductive by hydration with an electrolytic solution, that is, a solution containing sufficient ionic content to conduct energy such as RF energy. For medical use, the electrolytic solution is normally physiological saline, that is, a sterile approximately 0.9% aqueous sodium chloride solution that is isotonic with body fluids. Any salt solution at any desired concentration can, however, be used although it is preferred that the salt be one that is not detrimental to tissue or the health of the patient in the unlikely event that a balloon should inadvertently rupture. In another aspect, a balloon of this invention is intended for use in an ablation balloon catheter. For this use, a non-conductive mask is applied to a surface of the conductive hydrophilic balloon to create a pattern for ablation. Such a masked balloon is shown in Fig. 2. Balloon 105 has distal-facing surface 112 and proximal- facing suface 111. Proximal catheter shaft 100 protrudes from the proximal end of balloon 105 while catheter tip 101 protrudes from the distal end of balloon 105. The non-cross-hatched portions 1 10 of the surface of balloon 105 are non-conductive by virtue of a mask adhered to a surface of the balloon. The mask may be adhered to the outer or inner surface of the balloon. Cross-hatched portion 120 of the surface of balloon 105 is the conductive region. When the distal end of balloon 105 is inserted in a vessel such as the pulmonary vein of a patient from within the heart, region 120 is pressed up against the heart wall at the ostium or opening from the heart into the vein. A ground electrode is attached to a remote location on the patients body and then an RF signal is generated at the proximal end of the catheter proximal to section 100 of the catheter shaft (usually at a generator attached to the catheter in the vicinity of the handle) and is transmitted through wire 131 to electrode 130. The signal is conducted through region 120 of the balloon and a circuit is completed so that RF energy is delivered to the tissue in contact with region 120 and is thereby ablated. In order for a masked balloon of this invention to operate properly, the non- conductive polymer used to create the mask must have physical characteristics compatible with those of the hydrophilic polymer used to form the balloon. That is, at the very least, the non-conductive polymer must have a tensile strength and elasticity at least equivalent to that of the hydrophilic polymer so that the non- conductive polymer does not prematurely break when the balloon is inflated thus disrupting the desired ablation pattern. It is also necessary that the non-conductive polymer have chemical characteristics compatible with those of the hydrophilic polymer, at least insofar as is necessary to achieve sufficient adhesion of the non- conductive mask to the surface of the hydrophilic polymer balloon both in the dry and hydrated state. Sufficient adhesion means that the mask will remain in place and will not separate from the surface of the balloon either when the balloon is deflated, folded and stored in the catheter or when the balloon is deployed, hydrated and inflated. A wide range of non-conductive polymers can be used to create masks compatible with a TECOPHILIC® balloon. For example, without limitation, when the TECOPHILIC® balloon is formed by the dip-molding method, a preferred mask polymer is TECOFLEX® SG-85A, also manufactured by Thermedics Polymer Products. TECOFLEX®, like TECOPHILIC®, is a polyether-based aliphatic polyurethane and therefore is very compatible with TECOPHILIC® chemically so that masks formed from TECOFLEX® adhere well to surfaces made of TECOPHILIC®. In addition, the TECOFLEX has an ultimate tensile strength and elongation that is compatible with the TECOPHILIC. Other matching TECOFLEX® and TECOPHILIC® family member useful for making the balloons of this invention will become apparent to those skilled in the art based on the disclosure herein and are within the scope of this invention. When the TECOPHILIC® balloon is made by a blow-molding procedure, the masking polymers are preferably those that can be coated from an aqueous medium so as to avoid contacting the TECOPHILIC® with a solvent that might affect its integrity. An example, without limitation, of such a non-conductive masking polymer is NeoRez 967® from NeoResins, Wilmington Delaware. Of course, aqueous medium polymers may also be used with TECOPHILIC® balloons made by any method, not just blow-molded balloons so that, for example without limitation, NeoRez 967® could be substituted for TECOFLEX® in the above-described dip- coated balloon. If desired, the surface of the TECOPHIIC® balloon can be pre-treated to assist in prevention of bead formation during film formation and to enhance adhesion and coating uniformity. For example, without limitation, the surface of the TECOPHILIC® balloon can be subjected to an Argon plasma prior to coating. Based on the disclosures herein, other hydrophilic polymers that can be rendered conductive by hydration with electrolytic solutions and that have the requisite physical characteristics, other non-conductive polymers that are chemically and physically compatible with the hydrophilic polymer and other means of treatment of surfaces to enhance adhesion of the non-conductive mask polymer will become apparent to, or will be readily determinable without undue experimentation by, a skilled artisan. All such polymers and combinations of polymers are within the scope of this invention. In ablation therapy and in many other balloon catheter applications such as those mentioned in the Background section of this application, it is desirable, often necessary, to maintain the surface of the balloon that comprises the therapeutic element in intimate contact with a patient's tissue. As used herein, a "therapeutic element" simply refers to the features of that portion of a balloon that permits the desired therapy to be administered. For example, without limitation, for ablation therapy the therapeutic element is the conductive portion of the balloon that is in contact with the tissue to be ablated. For the administration of drugs, that portion of the balloon that is in contact with the patient's tissue must be permeable to the drug. Similarly, for brachytherapy, the portion of the balloon that is in contact with the tissue to be treated must be capable of retaining the radioactive material on its surface and then controllably depositing it at the target site. To maintain intimate contact of the therapeutic element of the balloon with the target tissue, a means for self-anchoring of the balloon in the correct orientation would be highly desirable. This can be accomplished using the essentially hourglass-shaped balloon of this invention shown in Fig. 3. In Fig. 3, balloon 300 is shown inflated in the locus of the ostium 310 of a vessel 320 in a patient's body. Balloon 300 consists of a first diameter 302, a second diameter 304 and a third diameter 306. Diameter 306 is smaller than either diameter 302 or diameter 304. Diameters 302 and 304, on the other hand, can be the same or different. In one embodiment, diameter 304 is less than diameter 302 (and diameter 306 is less than either of the other two). The catheter shaft 330, having distal end 335 and proximal end 337 is inserted into the vessel prior to inflation of the balloon. As the balloon inflates, the segment having diameter 302 expands and presses against wall 322 of vessel 320, causing it to dilate. The tissue 380 at the proximal side of the ostium is, in most circumstances, thicker than and therefore less elastic than the tissue of the wall 322 of the vessel. Thus, as the portion of balloon 300 having diameter 304 is increased by inflation of the balloon, the pressure of proximal-facing sloped surface 340 against wall 322 pulls distal- facing sloped surface 350 into intimate contact with tissue 380 in the vicinity of the ostium and holds it there thus relieving the operator of the chore of manually maintaining pressure on the balloon. This is at times referred to herein as self- anchoring of the balloon. For the purpose of illustration only, the balloon is shown as an ablation balloon. That is, the distal-facing sloped surface 350 is shown as having an energy- conductive band 380 that contacts tissue around the ostium. The remainer of the balloon is masked by a non-conductive polymer. Upon delivery of RF energy to the energy conductive region of the balloon, the contacted tissue is ablated. It is understood, however, that region 380 or, in fact, any or all portions of distal-facing sloped surface 350 that is in intimate contact with tissue may constitute a therapeutic element. That is, a drug could be diffused through surface 350 and infused into the tissue, radioactive beads could be removably adhered to surface 350 and transferred to the tissue, etc. In all these applications, the segment of the balloon having diameter 304 maintains the contact necessary to obtain the desired effect. FIG. 4 shows a tissue ablation system 400, which includes a balloon constructed in accordance with an embodiment of the invention. The system 400 includes an ablation catheter 410, a generator 420 for delivering energy to the catheter 410 to ablate tissue, an indifference electrode 430 (e.g., an electrode pad) coupled to the generator 420, and a source 432 of fluid coupled to the catheter 410. The catheter 410 comprises a handle assembly 440, a guide tube assembly 442, and an electrode assembly 444 having an inflatable balloon 710. During use, the guide tube assembly 442 delivers electrically conductive fluid from the fluid source 432 to inflate the balloon 710 at the electrode assembly 444. The generator 420 is coupled to the handle assembly 440 of the catheter 410 via a cable 446, so that radio frequency (RF) energy can be delivered to the electrode assembly 444. In the illustrated embodiment, the system 400 operates in a unipolar mode. In this arrangement, during use, the indifference electrode 430 is attached to a patient's back or other exterior skin area, and ablation energy will flow from the electrode assembly 444 to the patch electrode 430. Alternatively, the system 400 can be operated in a bipolar mode, in which case, the system 400 does not include the indifference electrode 430, and ablation energy will flow from one electrode on the electrode assembly 444 to an adjacent electrode (not shown) on the electrode assembly 444 or on the guide tube assembly 442. The guide tube assembly 442 includes an inner shaft 450 having a distal end
452, a proximal end 454, and a plurality of lumens 456 extending therebetween. As shown in FIG. 5, the shaft 450 also includes an inflation port 728 and a deflation port 730 located along the shaft 450, and a distal opening 732 at the distal tip of the shaft 450. In the illustrated embodiment, the shaft 450 includes four lumens 456a-456d. Lumen 456a, which is in fluid communication with the inflation port 728, is used to deliver fluid from the fluid source 432 to the electrode assembly 444 for inflation of the balloon 710. Lumen 456b, which is in fluid communication with the deflation port 730, is used to transport delivered fluid from the electrode assembly 444 back to the fluid source 432 or to another container for disposal of the fluid as the balloon 710 is deflated. Lumen 456c extends to the distal tip opening 732, and can be used to house a guidewire (not shown) that is inserted into the opening 732, through the shaft 450, and out of a port 441 located on the handle assembly 440. Lumen 456d is used to house wire(s) (e.g., RF lead wires and thermistor wires) that connect an electrically activated element at the electrode assembly 444 to the generator 420. It should be noted that the size and shape of the lumens 456 should not be limited to the example illustrated in the figure, and that the lumens 456 can have sizes and shapes that are different from that shown. In addition, the functionalities of the lumens 456 can vary. For example, in another embodiment, lumen 456c can be used to deliver radiopaque contrast to a target site. In the illustrated embodiment, the inner shaft 450 comprises a lower durometer Pebax braided shaft. However, the inner shaft 450 can also be made from a variety of materials, such as polymer, plastics, a thermoplastic material (e.g., plyurethane, polyolefin or polyetherpolyamide block copolymer). As shown in FIGS. 4 and 5, the guide tube assembly 442 also includes an outer shaft 480 coaxially surrounding the inner shaft 450 to strengthen and/or to improve a durability of the guide tube assembly 442, and an outer sheathing 490 secured to an outer surface of the outer shaft 480 for enhancing a stiffness of the guide tube assembly 442. Materials suitable for construction of the inner shaft 450 can also be used for the outer shaft 480. The diameter or the cross sectional dimension of the outer shaft 480 is preferably about 5.5 French (F). However, the outer shaft 480 can also have other cross sectional dimensions. The sheathing 490 can include, for example, a stainless steel coiled into a flexible spring, and a sheath of extruded plastic material containing wire braids enclosing the spring. Such construction provides additional torsional stiffness to the shaft 450, thereby allowing a torquing force to be transmitted from the handle assembly 440 to the electrode assembly 444 of the catheter 410. In the illustrated embodiment, the outer sheathing 490 does not extend completely to the distal end of the catheter 410. Alternatively, the outer sheathing 490 can extend to a proximal end of the electrode assembly 444 or to the distal end 452 of the inner shaft 450. The electrode assembly 444 will now be described with reference to FIG. 5. The electrode assembly 444 includes an electrode 700 secured to the guide tube assembly 442, and a balloon 710. The balloon 710 has a distal end 712 and a proximal end 714 secured to the guide tube assembly 442. The balloon 710 also has a conductive region 716 located between the distal and proximal ends 712, 714. In the illustrated embodiment, the electrode 700 is a coil having a lumen that extends between the ends of the coil. Ablation wires (not shown) connect the electrode 700 to the generator 420, and are housed in one of the lumens 456 of the shaft 450. The electrode 700 is secured to the shaft 450 by a suitable adhesive at both ends of the electrode 700. Alternatively, the electrode 700 can be secured to the shaft 450 at other locations of the electrode 700. Using a coil for construction of the electrode 700 is advantageous in that it allows the shaft 450 to easily deflect or bend as the shaft 450 is delivered over a guidewire. The coil electrode 700 also provides a large electrode surface to improve heat dissipation and lower impedance during use. The shaft 450 has a section 720 with a diameter or cross sectional dimension that is less than that of an adjacent section of the shaft 450, such that when the electrode coil 700 is placed around the section 720, the electrode 700 will substantially flush with an exterior surface of the outer shaft 480 to form a smooth surface. Such configuration reduces the overall profile of the electrode assembly 444, and reduces the risk of the electrode 700 abrading the balloon 710 during use. In the illustrated embodiment, the electrode 700 is positioned proximal to the conductive region 716 of the balloon 710. Such configuration prevents the electrode 700 from abrading the conductive region 716 of the balloon 710 during use (e.g., while inserting the balloon 710 into a delivery or access tube), and allows the electrode assembly 444 to form more uniform lesions without excessive charring. Alternatively, the electrode 700 can be placed distal to the conductive region 716, or at the same axial location along an axis 760 of the inner shaft 750. It should be noted that the configurations of the electrode 700 and the balloon 710 are not limited to those shown in the figure. In alternative embodiments, the electrode 700 can have a shape of a ring, a tubular segment, or other shapes, and the balloon 710 can have other shapes, such as a spherical shape, an elliptical shape, or a dumbbell shape. In addition, instead of extending through the balloon 710, in an alternative embodiment, the distal end 452 of the shaft 450 does not penetrate through the balloon 710. Instead, the balloon 710 has a closed distal end 712, and the electrode 700 is secured to the distal end 452 of the shaft 450, which is disposed within a lumen 734 of the balloon 710. In such case, the distal end 452 of the shaft 500 has one or more openings that are in fluid communication with the one or more lumens 456 of the shaft 450 for delivering and draining fluid to and from the lumen 734 of the balloon 710. Alternatively, the distal end 452 of the shaft 450 has a closed tip, in which case, the shaft 450 has one or more openings 728 along its length for delivering and draining inflation fluid to and from the balloon 710, as similarly discussed previously. Furthermore, instead of securing to the shaft 450, the electrode 700 can be secured to a distal end of an elongate structure, such as a pusher, which is slidably disposed within one of the lumens 456 of the shaft 450. Such configuration allows a position of the electrode 700 along the axis 760 of the shaft 450 be adjusted during use. As shown in FIG. 5, the electrode assembly 444 also includes a sensor 790, such as a thermistor, secured to the inner shaft 450. The outer shaft 480 has an opening 792 and the inner shaft 450 has a recess 794 for accommodating the sensor 790. The recess 794 has a depth such that when the sensor 790 is attached to the inner shaft 450, the sensor 790 lies substantially flush with an exterior surface of the outer shaft 480. It should be noted that the sensor 790 is not necessarily limited to a thermistor, and that the sensor 790 can be a variety of sensing devices, such as an impedance sensor or a current sensor. A method of using the system 400 will now be described with reference to cardiac ablation therapy. When using the system 400 for cardiac ablation therapy, a physician inserts a guidewire through a main vein or artery (typically the femoral vein or artery) of a patient into an interior region of a heart that is to be treated. The physician then inserts a proximal end of the guidewire into the distal opening 732 of the inner shaft 750, and distally advances the electrode assembly 444 over the guidewire until the electrode assembly 444 reaches a treatment site. In one embodiment, an access shaft or tube can be provided and inserted over the guidewire. In such case, the electrode assembly 444 can be placed in the access shaft and distally advanced to reach the treatment site. Alternatively, the electrode assembly 444 can be placed within the access shaft first, and the electrode assembly 444 together with the access shaft are then delivered over the guidewire, and advanced to the treatment site. In another embodiment, the catheter 410 can include a steering mechanism for steering a distal end of the catheter 410. In such case, the use of the guidewire and/or the access shaft may not be required, and the physician can place the electrode assembly 444 into contact with a tissue within the heart that is targeted for ablation by operating the steering mechanism. When the electrode assembly 444 is desirably positioned, inflation fluid, such as an electrically conductive fluid, is then delivered from the fluid source 432 to the electrode assembly 444. Particularly, the fluid exits through inflation port 728 to inflate the balloon 710. Energy is then directed from the generator 420 to the electrode 700, and energy will flow from the electrode 700 to the conductive region 716 via the delivered conductive fluid to ablate the tissue and form a lesion on the tissue. When a desired lesion has been created, the delivered fluid can be drained from the lumen 734 of the balloon 710 to deflate the balloon 710, and the catheter 410 can be removed from the patient.

Claims

1. A balloon catheter comprising a distally-located inflatable balloon comprising an energy-conductive hydrophilic polymer having a tensile strength of at least 3000 psi, wherein the balloon is molded to inflate to specified equilibrium dimensions when subjected to about one atmosphere of internal pressure.
2. The balloon catheter of claim 1 , wherein the hydrophilic polymer further has an elasticity that permits the balloon to inflate to dimensions greater than its equilibrium dimensions under more than one atmosphere of internal pressure without failing.
3. The balloon catheter of claim 2, wherein the balloon can be inflated to dimensions at least 50% greater than its equilibrium dimensions.
4. The balloon catheter of any one of claims 1 , 2 or 3, wherein the hydrophilic polymer, when hydrated, comprises from 10 volume percent to about 40 volume percent water.
5. The balloon catheter of claim 4, wherein the hydrophilic polymer, when hydrated, comprises about 20% volume percent water.
6. The balloon catheter of either claim 1 , wherein the hydrophilic polymer comprises a conductive homopolymeric or co-polymeric thermoplastic polyurethane when hydrated with an electrolytic solution.
7. The balloon catheter of claim 6, wherein the thermoplastic polyurethane is TECOPHILIC® .
8. The balloon catheter of claim 1 , further comprising a non-conductive polymer mask adhered to a surface of the balloon to create a pattern of conductive and non-conductive areas wherein the non-conductive polymer has physical and chemical characteristics compatible with those of the hydrophilic polymer.
9. The balloon catheter of claim 8, wherein the non-conductive polymer comprises a non-conductive homopolymeric or co-polymeric thermoplastic polyurethane.
10. The balloon catheter of claim 9, wherein the non-conductive polyurethane is TECOFLEX®.
1 1. The balloon catheter of claim 8 wherein the non-conductive polymer is NeoRez 967®.
12. The balloon catheter of claim 1 , wherein the conductive areas of the balloon have a wall thickness of from about 0.0005" to about 0.005".
PCT/US2004/029059 2003-09-15 2004-09-03 Catheter balloons comprising an energy-conductive hydrophilic polymer WO2005032636A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/663,176 2003-09-15
US10/663,176 US7736362B2 (en) 2003-09-15 2003-09-15 Catheter balloons

Publications (1)

Publication Number Publication Date
WO2005032636A1 true WO2005032636A1 (en) 2005-04-14

Family

ID=34274303

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/029059 WO2005032636A1 (en) 2003-09-15 2004-09-03 Catheter balloons comprising an energy-conductive hydrophilic polymer

Country Status (2)

Country Link
US (1) US7736362B2 (en)
WO (1) WO2005032636A1 (en)

Families Citing this family (226)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7004938B2 (en) * 2001-11-29 2006-02-28 Medwaves, Inc. Radio-frequency-based catheter system with improved deflection and steering mechanisms
US20070066972A1 (en) * 2001-11-29 2007-03-22 Medwaves, Inc. Ablation catheter apparatus with one or more electrodes
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
EP2452648B1 (en) 2003-09-12 2016-02-10 Vessix Vascular, Inc. System for selectable eccentric remodeling and/or ablation of atherosclerotic material
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
US9713730B2 (en) 2004-09-10 2017-07-25 Boston Scientific Scimed, Inc. Apparatus and method for treatment of in-stent restenosis
US20080015569A1 (en) 2005-02-02 2008-01-17 Voyage Medical, Inc. Methods and apparatus for treatment of atrial fibrillation
US8050746B2 (en) 2005-02-02 2011-11-01 Voyage Medical, Inc. Tissue visualization device and method variations
US7918787B2 (en) * 2005-02-02 2011-04-05 Voyage Medical, Inc. Tissue visualization and manipulation systems
US11478152B2 (en) 2005-02-02 2022-10-25 Intuitive Surgical Operations, Inc. Electrophysiology mapping and visualization system
US7860555B2 (en) 2005-02-02 2010-12-28 Voyage Medical, Inc. Tissue visualization and manipulation system
US7860556B2 (en) * 2005-02-02 2010-12-28 Voyage Medical, Inc. Tissue imaging and extraction systems
US7930016B1 (en) 2005-02-02 2011-04-19 Voyage Medical, Inc. Tissue closure system
US10064540B2 (en) 2005-02-02 2018-09-04 Intuitive Surgical Operations, Inc. Visualization apparatus for transseptal access
US8078266B2 (en) 2005-10-25 2011-12-13 Voyage Medical, Inc. Flow reduction hood systems
US9510732B2 (en) 2005-10-25 2016-12-06 Intuitive Surgical Operations, Inc. Methods and apparatus for efficient purging
US8137333B2 (en) 2005-10-25 2012-03-20 Voyage Medical, Inc. Delivery of biological compounds to ischemic and/or infarcted tissue
US20070083192A1 (en) * 2005-10-07 2007-04-12 Eric Welch Apparatus and method for ablation of targeted tissue
US8221310B2 (en) 2005-10-25 2012-07-17 Voyage Medical, Inc. Tissue visualization device and method variations
US20070219488A1 (en) * 2005-12-16 2007-09-20 Darius Francescatti Active drainage system for use in defined natural or surgically created body cavities or lumina
FR2896167B1 (en) * 2006-01-18 2008-10-24 Chu Clermont Ferrand SEALED RECTAL PROBE
US8019435B2 (en) 2006-05-02 2011-09-13 Boston Scientific Scimed, Inc. Control of arterial smooth muscle tone
US9055906B2 (en) 2006-06-14 2015-06-16 Intuitive Surgical Operations, Inc. In-vivo visualization systems
US10004388B2 (en) 2006-09-01 2018-06-26 Intuitive Surgical Operations, Inc. Coronary sinus cannulation
US20080097476A1 (en) 2006-09-01 2008-04-24 Voyage Medical, Inc. Precision control systems for tissue visualization and manipulation assemblies
WO2008028149A2 (en) 2006-09-01 2008-03-06 Voyage Medical, Inc. Electrophysiology mapping and visualization system
WO2008049087A2 (en) 2006-10-18 2008-04-24 Minnow Medical, Inc. System for inducing desirable temperature effects on body tissue
CA2666661C (en) 2006-10-18 2015-01-20 Minnow Medical, Inc. Tuned rf energy and electrical tissue characterization for selective treatment of target tissues
WO2008049082A2 (en) 2006-10-18 2008-04-24 Minnow Medical, Inc. Inducing desirable temperature effects on body tissue
US10335131B2 (en) 2006-10-23 2019-07-02 Intuitive Surgical Operations, Inc. Methods for preventing tissue migration
US20080140074A1 (en) * 2006-12-07 2008-06-12 Cierra, Inc. Multi-electrode apparatus for tissue welding and ablation
US20080183036A1 (en) 2006-12-18 2008-07-31 Voyage Medical, Inc. Systems and methods for unobstructed visualization and ablation
US8758229B2 (en) 2006-12-21 2014-06-24 Intuitive Surgical Operations, Inc. Axial visualization systems
US8131350B2 (en) 2006-12-21 2012-03-06 Voyage Medical, Inc. Stabilization of visualization catheters
WO2008099380A2 (en) 2007-02-15 2008-08-21 Cardionova Ltd. Intra-atrial apparatus and method of use thereof
US8166783B2 (en) * 2007-02-23 2012-05-01 Master Lock Company Llc Anti-tampering arrangements for pin tumbler cylinder locks
US9155452B2 (en) 2007-04-27 2015-10-13 Intuitive Surgical Operations, Inc. Complex shape steerable tissue visualization and manipulation catheter
US8657805B2 (en) 2007-05-08 2014-02-25 Intuitive Surgical Operations, Inc. Complex shape steerable tissue visualization and manipulation catheter
US20080281317A1 (en) * 2007-05-10 2008-11-13 Fred Gobel Endometrial Ablation catheter
US8709008B2 (en) 2007-05-11 2014-04-29 Intuitive Surgical Operations, Inc. Visual electrode ablation systems
US20090030276A1 (en) * 2007-07-27 2009-01-29 Voyage Medical, Inc. Tissue visualization catheter with imaging systems integration
DE102007036685A1 (en) * 2007-08-03 2009-02-05 Innora Gmbh Improved drug-coated medical devices their manufacture and use
DE102007040868A1 (en) * 2007-08-29 2009-04-16 Innora Gmbh Balloon catheter with protection against unfolding
US20090062790A1 (en) * 2007-08-31 2009-03-05 Voyage Medical, Inc. Direct visualization bipolar ablation systems
US8235985B2 (en) 2007-08-31 2012-08-07 Voyage Medical, Inc. Visualization and ablation system variations
US8858609B2 (en) 2008-02-07 2014-10-14 Intuitive Surgical Operations, Inc. Stent delivery under direct visualization
CA2727429C (en) 2008-06-13 2016-01-26 Daniel Hawkins Shockwave balloon catheter system
US10702293B2 (en) 2008-06-13 2020-07-07 Shockwave Medical, Inc. Two-stage method for treating calcified lesions within the wall of a blood vessel
US9101735B2 (en) 2008-07-07 2015-08-11 Intuitive Surgical Operations, Inc. Catheter control systems
US9198968B2 (en) * 2008-09-15 2015-12-01 The Spectranetics Corporation Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US8128951B2 (en) * 2008-09-15 2012-03-06 Cv Ingenuity Corp. Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US8114429B2 (en) 2008-09-15 2012-02-14 Cv Ingenuity Corp. Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US8257722B2 (en) 2008-09-15 2012-09-04 Cv Ingenuity Corp. Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US8894643B2 (en) 2008-10-10 2014-11-25 Intuitive Surgical Operations, Inc. Integral electrode placement and connection systems
CA2739326A1 (en) 2008-10-10 2010-04-15 Intervalve, Inc. Valvuloplasty catheter and methods
US8333012B2 (en) 2008-10-10 2012-12-18 Voyage Medical, Inc. Method of forming electrode placement and connection systems
US9662163B2 (en) 2008-10-21 2017-05-30 Hermes Innovations Llc Endometrial ablation devices and systems
US8821486B2 (en) 2009-11-13 2014-09-02 Hermes Innovations, LLC Tissue ablation systems and methods
US8500732B2 (en) 2008-10-21 2013-08-06 Hermes Innovations Llc Endometrial ablation devices and systems
US8540708B2 (en) 2008-10-21 2013-09-24 Hermes Innovations Llc Endometrial ablation method
US8197476B2 (en) 2008-10-21 2012-06-12 Hermes Innovations Llc Tissue ablation systems
US8372068B2 (en) 2008-10-21 2013-02-12 Hermes Innovations, LLC Tissue ablation systems
US8197477B2 (en) 2008-10-21 2012-06-12 Hermes Innovations Llc Tissue ablation methods
US9044618B2 (en) 2008-11-05 2015-06-02 Shockwave Medical, Inc. Shockwave valvuloplasty catheter system
US9468364B2 (en) 2008-11-14 2016-10-18 Intuitive Surgical Operations, Inc. Intravascular catheter with hood and image processing systems
WO2010056745A1 (en) 2008-11-17 2010-05-20 Minnow Medical, Inc. Selective accumulation of energy with or without knowledge of tissue topography
EP2395934B1 (en) 2009-02-11 2019-04-17 Boston Scientific Scimed, Inc. Insulated ablation catheter devices
WO2011008444A1 (en) 2009-06-30 2011-01-20 Boston Scientific Scimed, Inc. Map and ablate open irrigated hybrid catheter
CA2775588C (en) 2009-10-02 2019-02-05 Medtronic Xomed, Inc. Endotracheal tube apparatus
WO2011042893A1 (en) * 2009-10-09 2011-04-14 Flip Technologies Limited A device and a method for facilitating monitoring the cross-section of a gastric sleeve during formation thereof
US8715278B2 (en) 2009-11-11 2014-05-06 Minerva Surgical, Inc. System for endometrial ablation utilizing radio frequency
US11896282B2 (en) 2009-11-13 2024-02-13 Hermes Innovations Llc Tissue ablation systems and method
US8529562B2 (en) 2009-11-13 2013-09-10 Minerva Surgical, Inc Systems and methods for endometrial ablation
US9289257B2 (en) 2009-11-13 2016-03-22 Minerva Surgical, Inc. Methods and systems for endometrial ablation utilizing radio frequency
DE112010004615B4 (en) * 2009-11-30 2023-05-17 Medwaves, Inc. RADIO FREQUENCY ABLATION SYSTEM WITH TRACKING SENSOR
DK2528575T3 (en) 2010-01-28 2016-08-15 Art Healthcare Ltd DEFLECTION DETECTION AND / OR BLOCK DEVICE
US8694071B2 (en) 2010-02-12 2014-04-08 Intuitive Surgical Operations, Inc. Image stabilization techniques and methods
EP2549974B1 (en) 2010-03-22 2016-10-26 ART Healthcare Ltd. Naso/orogastric tube having one or more backflow blocking elements, backflow blocking elements, and a method of using backflow blocking elements
US9814522B2 (en) 2010-04-06 2017-11-14 Intuitive Surgical Operations, Inc. Apparatus and methods for ablation efficacy
JP2013523318A (en) 2010-04-09 2013-06-17 べシックス・バスキュラー・インコーポレイテッド Power generation and control equipment for tissue treatment
US9192790B2 (en) 2010-04-14 2015-11-24 Boston Scientific Scimed, Inc. Focused ultrasonic renal denervation
US9987153B2 (en) 2010-06-08 2018-06-05 The Regents Of The University Of Minnesota Vascular elastance
US8473067B2 (en) 2010-06-11 2013-06-25 Boston Scientific Scimed, Inc. Renal denervation and stimulation employing wireless vascular energy transfer arrangement
US8956348B2 (en) 2010-07-21 2015-02-17 Minerva Surgical, Inc. Methods and systems for endometrial ablation
US9408661B2 (en) 2010-07-30 2016-08-09 Patrick A. Haverkost RF electrodes on multiple flexible wires for renal nerve ablation
US9155589B2 (en) 2010-07-30 2015-10-13 Boston Scientific Scimed, Inc. Sequential activation RF electrode set for renal nerve ablation
US9463062B2 (en) * 2010-07-30 2016-10-11 Boston Scientific Scimed, Inc. Cooled conductive balloon RF catheter for renal nerve ablation
US9358365B2 (en) 2010-07-30 2016-06-07 Boston Scientific Scimed, Inc. Precision electrode movement control for renal nerve ablation
US9084609B2 (en) 2010-07-30 2015-07-21 Boston Scientific Scime, Inc. Spiral balloon catheter for renal nerve ablation
US8974451B2 (en) 2010-10-25 2015-03-10 Boston Scientific Scimed, Inc. Renal nerve ablation using conductive fluid jet and RF energy
US9220558B2 (en) 2010-10-27 2015-12-29 Boston Scientific Scimed, Inc. RF renal denervation catheter with multiple independent electrodes
US9510897B2 (en) 2010-11-05 2016-12-06 Hermes Innovations Llc RF-electrode surface and method of fabrication
US9028485B2 (en) 2010-11-15 2015-05-12 Boston Scientific Scimed, Inc. Self-expanding cooling electrode for renal nerve ablation
US9089350B2 (en) 2010-11-16 2015-07-28 Boston Scientific Scimed, Inc. Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
US9668811B2 (en) 2010-11-16 2017-06-06 Boston Scientific Scimed, Inc. Minimally invasive access for renal nerve ablation
US9326751B2 (en) 2010-11-17 2016-05-03 Boston Scientific Scimed, Inc. Catheter guidance of external energy for renal denervation
US9060761B2 (en) 2010-11-18 2015-06-23 Boston Scientific Scime, Inc. Catheter-focused magnetic field induced renal nerve ablation
US9023034B2 (en) 2010-11-22 2015-05-05 Boston Scientific Scimed, Inc. Renal ablation electrode with force-activatable conduction apparatus
US9192435B2 (en) 2010-11-22 2015-11-24 Boston Scientific Scimed, Inc. Renal denervation catheter with cooled RF electrode
WO2012071395A1 (en) * 2010-11-22 2012-05-31 Aria Cv, Inc. System and method for reducing pulsatile pressure
US8992519B2 (en) * 2010-11-23 2015-03-31 Boston Scientific Scime, Inc. Inverted balloon RF ablation catheter and method
US20120157993A1 (en) 2010-12-15 2012-06-21 Jenson Mark L Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
US9089340B2 (en) 2010-12-30 2015-07-28 Boston Scientific Scimed, Inc. Ultrasound guided tissue ablation
US9220561B2 (en) 2011-01-19 2015-12-29 Boston Scientific Scimed, Inc. Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
CA2832311A1 (en) 2011-04-08 2012-11-29 Covidien Lp Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
CN103930061B (en) 2011-04-25 2016-09-14 美敦力阿迪安卢森堡有限责任公司 Relevant low temperature sacculus for restricted conduit wall cryogenic ablation limits the device and method disposed
AU2012262959A1 (en) 2011-06-01 2013-11-28 Boston Scientific Scimed, Inc. Ablation probe with ultrasonic imaging capabilities
WO2013013156A2 (en) 2011-07-20 2013-01-24 Boston Scientific Scimed, Inc. Percutaneous devices and methods to visualize, target and ablate nerves
EP2734264B1 (en) 2011-07-22 2018-11-21 Boston Scientific Scimed, Inc. Nerve modulation system with a nerve modulation element positionable in a helical guide
CA2847846A1 (en) * 2011-09-14 2013-03-21 Boston Scientific Scimed, Inc. Ablation device with multiple ablation modes
US9125668B2 (en) 2011-09-14 2015-09-08 Boston Scientific Scimed Inc. Ablation device with multiple ablation modes
EP2755588B1 (en) 2011-09-14 2016-05-18 Boston Scientific Scimed, Inc. Ablation device with ionically conductive balloon
WO2013055826A1 (en) 2011-10-10 2013-04-18 Boston Scientific Scimed, Inc. Medical devices including ablation electrodes
US10085799B2 (en) 2011-10-11 2018-10-02 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
US9420955B2 (en) 2011-10-11 2016-08-23 Boston Scientific Scimed, Inc. Intravascular temperature monitoring system and method
US9364284B2 (en) 2011-10-12 2016-06-14 Boston Scientific Scimed, Inc. Method of making an off-wall spacer cage
US9079000B2 (en) 2011-10-18 2015-07-14 Boston Scientific Scimed, Inc. Integrated crossing balloon catheter
US9162046B2 (en) 2011-10-18 2015-10-20 Boston Scientific Scimed, Inc. Deflectable medical devices
US8574247B2 (en) 2011-11-08 2013-11-05 Shockwave Medical, Inc. Shock wave valvuloplasty device with moveable shock wave generator
CN108095821B (en) 2011-11-08 2021-05-25 波士顿科学西美德公司 Orifice renal nerve ablation
WO2013074813A1 (en) 2011-11-15 2013-05-23 Boston Scientific Scimed, Inc. Device and methods for renal nerve modulation monitoring
US9119632B2 (en) 2011-11-21 2015-09-01 Boston Scientific Scimed, Inc. Deflectable renal nerve ablation catheter
US9265969B2 (en) 2011-12-21 2016-02-23 Cardiac Pacemakers, Inc. Methods for modulating cell function
AU2012358143B2 (en) 2011-12-23 2015-06-11 Boston Scientific Scimed, Inc. Expandable balloon or an electrode pad with a heat sensing device
US9433760B2 (en) 2011-12-28 2016-09-06 Boston Scientific Scimed, Inc. Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements
CN104125811B (en) 2011-12-28 2016-10-26 波士顿科学医学有限公司 There is the excision probe of ultrasonic imaging capability
US9050106B2 (en) 2011-12-29 2015-06-09 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
US9931079B2 (en) 2012-01-04 2018-04-03 Medtronic Xomed, Inc. Clamp for securing a terminal end of a wire to a surface electrode
WO2013106557A1 (en) 2012-01-10 2013-07-18 Boston Scientific Scimed, Inc. Electrophysiology system
WO2013115941A1 (en) 2012-01-31 2013-08-08 Boston Scientific Scimed, Inc. Ablation probe with fluid-based acoustic coupling for ultrasonic tissue imaging
US8992514B2 (en) 2012-02-24 2015-03-31 Isolase, Ltd. Ablation techniques for the treatment of atrial fibrillation
US20130274730A1 (en) * 2012-04-12 2013-10-17 Boston Scientific Scimed, Inc. Ablation catheter and methods for nerve modulation
US10660703B2 (en) * 2012-05-08 2020-05-26 Boston Scientific Scimed, Inc. Renal nerve modulation devices
US9956385B2 (en) 2012-06-28 2018-05-01 The Spectranetics Corporation Post-processing of a medical device to control morphology and mechanical properties
US20140018888A1 (en) * 2012-07-16 2014-01-16 Boston Scientific Scimed, Inc. Flow controlled radiofrequency medical balloon
CN104540465A (en) * 2012-08-24 2015-04-22 波士顿科学西美德公司 Intravascular catheter with a balloon comprising separate microporous regions
CN104768487A (en) 2012-09-13 2015-07-08 波士顿科学西美德公司 Renal nerve modulation balloon and methods of making and using the same
WO2014043687A2 (en) 2012-09-17 2014-03-20 Boston Scientific Scimed, Inc. Self-positioning electrode system and method for renal nerve modulation
WO2014047071A1 (en) 2012-09-18 2014-03-27 Boston Scientific Scimed, Inc. Map and ablate closed-loop cooled ablation catheter with flat tip
WO2014047068A1 (en) 2012-09-18 2014-03-27 Boston Scientific Scimed, Inc. Map and ablate closed-loop cooled ablation catheter
WO2014047454A2 (en) 2012-09-21 2014-03-27 Boston Scientific Scimed, Inc. Self-cooling ultrasound ablation catheter
WO2014047411A1 (en) 2012-09-21 2014-03-27 Boston Scientific Scimed, Inc. System for nerve modulation and innocuous thermal gradient nerve block
US20140088586A1 (en) * 2012-09-26 2014-03-27 Boston Scientific Scimed, Inc. Renal nerve modulation devices
US20140088584A1 (en) * 2012-09-26 2014-03-27 Boston Scientific Scimed, Inc. Medical device balloon catheter
ES2628528T3 (en) 2012-10-01 2017-08-03 C.R. Bard, Inc Balloon catheter that has multiple inflation lights
JP6074051B2 (en) 2012-10-10 2017-02-01 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Intravascular neuromodulation system and medical device
US10342608B2 (en) 2012-10-18 2019-07-09 The Board Of Trustees Of The Leland Stanford Junior University Ablation catheter system and method for deploying same
US10286182B2 (en) * 2012-11-12 2019-05-14 Boston Scientific Scimed, Inc. Renal catheter shaft design
US9060744B2 (en) 2012-11-29 2015-06-23 Medtronic Xomed, Inc. Endobronchial tube apparatus
US20140180248A1 (en) * 2012-12-23 2014-06-26 Erez Salik Osmotic Ablation Device
WO2014163987A1 (en) * 2013-03-11 2014-10-09 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
WO2014143571A1 (en) 2013-03-11 2014-09-18 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
JP2016508834A (en) * 2013-03-13 2016-03-24 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Steerable ablation device with linear ion conducting balloon
US9808311B2 (en) 2013-03-13 2017-11-07 Boston Scientific Scimed, Inc. Deflectable medical devices
US9913594B2 (en) 2013-03-14 2018-03-13 Medtronic Xomed, Inc. Compliant electrode for EMG endotracheal tube
US10265122B2 (en) 2013-03-15 2019-04-23 Boston Scientific Scimed, Inc. Nerve ablation devices and related methods of use
US9827039B2 (en) 2013-03-15 2017-11-28 Boston Scientific Scimed, Inc. Methods and apparatuses for remodeling tissue of or adjacent to a body passage
CN105228546B (en) 2013-03-15 2017-11-14 波士顿科学国际有限公司 Utilize the impedance-compensated medicine equipment and method that are used to treat hypertension
US9901394B2 (en) 2013-04-04 2018-02-27 Hermes Innovations Llc Medical ablation system and method of making
EP3010437A1 (en) 2013-06-21 2016-04-27 Boston Scientific Scimed, Inc. Renal denervation balloon catheter with ride along electrode support
JP2016524949A (en) 2013-06-21 2016-08-22 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Medical device for renal nerve ablation having a rotatable shaft
US9707036B2 (en) 2013-06-25 2017-07-18 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation using localized indifferent electrodes
AU2014284558B2 (en) 2013-07-01 2017-08-17 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
EP3019106A1 (en) 2013-07-11 2016-05-18 Boston Scientific Scimed, Inc. Medical device with stretchable electrode assemblies
US10660698B2 (en) 2013-07-11 2020-05-26 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation
EP3049007B1 (en) 2013-07-19 2019-06-12 Boston Scientific Scimed, Inc. Spiral bipolar electrode renal denervation balloon
JP6122217B2 (en) 2013-07-22 2017-04-26 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Renal nerve ablation medical device
WO2015013205A1 (en) 2013-07-22 2015-01-29 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
CN105473093B (en) 2013-08-22 2019-02-05 波士顿科学国际有限公司 Flexible circuit with the improved adhesion strength to renal nerve modulation sacculus
CN105555218B (en) 2013-09-04 2019-01-15 波士顿科学国际有限公司 With radio frequency (RF) foley's tube rinsed with cooling capacity
EP3043733A1 (en) 2013-09-13 2016-07-20 Boston Scientific Scimed, Inc. Ablation balloon with vapor deposited cover layer
US11246654B2 (en) 2013-10-14 2022-02-15 Boston Scientific Scimed, Inc. Flexible renal nerve ablation devices and related methods of use and manufacture
US9687166B2 (en) 2013-10-14 2017-06-27 Boston Scientific Scimed, Inc. High resolution cardiac mapping electrode array catheter
US9770606B2 (en) 2013-10-15 2017-09-26 Boston Scientific Scimed, Inc. Ultrasound ablation catheter with cooling infusion and centering basket
WO2015057584A1 (en) 2013-10-15 2015-04-23 Boston Scientific Scimed, Inc. Medical device balloon
US9649125B2 (en) 2013-10-15 2017-05-16 Hermes Innovations Llc Laparoscopic device
WO2015057961A1 (en) 2013-10-18 2015-04-23 Boston Scientific Scimed, Inc. Balloon catheters with flexible conducting wires and related methods of use and manufacture
WO2015061457A1 (en) 2013-10-25 2015-04-30 Boston Scientific Scimed, Inc. Embedded thermocouple in denervation flex circuit
US9757273B2 (en) * 2013-12-20 2017-09-12 Novartis Ag Tissue-sensing vitrectomy surgical systems and methods
WO2015103617A1 (en) 2014-01-06 2015-07-09 Boston Scientific Scimed, Inc. Tear resistant flex circuit assembly
US10525171B2 (en) 2014-01-24 2020-01-07 The Spectranetics Corporation Coatings for medical devices
EP3102136B1 (en) 2014-02-04 2018-06-27 Boston Scientific Scimed, Inc. Alternative placement of thermal sensors on bipolar electrode
US11000679B2 (en) 2014-02-04 2021-05-11 Boston Scientific Scimed, Inc. Balloon protection and rewrapping devices and related methods of use
US10709490B2 (en) 2014-05-07 2020-07-14 Medtronic Ardian Luxembourg S.A.R.L. Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods
US8876850B1 (en) 2014-06-19 2014-11-04 Aria Cv, Inc. Systems and methods for treating pulmonary hypertension
JP6282209B2 (en) * 2014-10-08 2018-02-21 日本ライフライン株式会社 Chemical ablation device and chemical ablation system
CN106793968A (en) 2014-10-13 2017-05-31 波士顿科学医学有限公司 Organizational diagnosis and treatment using microelectrode
EP3209234B1 (en) 2014-10-24 2023-11-29 Boston Scientific Scimed Inc. Medical devices with a flexible electrode assembly coupled to an ablation tip
WO2016100917A1 (en) 2014-12-18 2016-06-23 Boston Scientific Scimed Inc. Real-time morphology analysis for lesion assessment
WO2016118923A1 (en) * 2015-01-22 2016-07-28 Intersect Ent, Inc. Drug-coated balloon
US10492856B2 (en) 2015-01-26 2019-12-03 Hermes Innovations Llc Surgical fluid management system and method of use
US10376308B2 (en) 2015-02-05 2019-08-13 Axon Therapies, Inc. Devices and methods for treatment of heart failure by splanchnic nerve ablation
US10086213B2 (en) * 2015-04-23 2018-10-02 Mark A. D'Andrea Mobile gynecological balloon devices and methods
JP6814746B2 (en) 2015-04-29 2021-01-20 シーラス テクノロジーズ リミテッド Medical ablation device and usage
US10052149B2 (en) 2016-01-20 2018-08-21 RELIGN Corporation Arthroscopic devices and methods
US11253311B2 (en) 2016-04-22 2022-02-22 RELIGN Corporation Arthroscopic devices and methods
EP3478197A4 (en) 2016-07-01 2020-04-29 Relign Corporation Arthroscopic devices and methods
CN109843160B (en) 2016-07-29 2022-04-15 阿克松疗法公司 Devices, systems, and methods for treating heart failure through cardiac nerve ablation
EP4309608A3 (en) 2016-10-06 2024-04-17 Shockwave Medical, Inc. Aortic leaflet repair using shock wave applicators
WO2018075552A1 (en) 2016-10-19 2018-04-26 Aria Cv, Inc. Diffusion resistant implantable devices for reducing pulsatile pressure
JP6811319B2 (en) * 2016-10-26 2021-01-13 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Stenosis prevention and ablation transfer system
EP3538000A4 (en) 2016-11-08 2020-04-01 Innoblative Designs, Inc. Electrosurgical tissue and vessel sealing device
US10357264B2 (en) 2016-12-06 2019-07-23 Shockwave Medical, Inc. Shock wave balloon catheter with insertable electrodes
US20200008869A1 (en) * 2016-12-15 2020-01-09 St. Jude Medical, Cardiology Division, Inc. Pulmonary vein isolation balloon catheter
EP3534816B1 (en) * 2017-01-06 2021-12-08 St. Jude Medical, Cardiology Division, Inc. Pulmonary vein isolation balloon catheter
US20200129218A1 (en) * 2017-06-05 2020-04-30 St. Jude Medical, Cardiology Division, Inc. Pulmonary antrum radial-linear ablation devices
US10966737B2 (en) 2017-06-19 2021-04-06 Shockwave Medical, Inc. Device and method for generating forward directed shock waves
EP3658053B1 (en) 2017-07-26 2023-09-13 Innoblative Designs, Inc. Minimally invasive articulating assembly having ablation capabilities
EP4292641A3 (en) 2017-08-22 2024-03-13 Medtronic Xomed, Inc. System for evoking a reflex to monitor the nerves of the larynx
US11110240B2 (en) 2017-09-07 2021-09-07 Medtronic Xomed, Inc. Endotracheal tube with tube coating
US10561461B2 (en) 2017-12-17 2020-02-18 Axon Therapies, Inc. Methods and devices for endovascular ablation of a splanchnic nerve
EP3743147B1 (en) 2018-01-26 2024-04-10 Axon Therapies, Inc. Device for endovascular ablation of a splanchnic nerve
ES2948245T3 (en) 2018-06-21 2023-09-06 Shockwave Medical Inc System for the treatment of occlusions in body lights
US20220233819A1 (en) * 2019-06-10 2022-07-28 The Regents Of The University Of Michigan Repositionable medical tube with ultrasonically-detectable cuff
EP4241836A3 (en) 2019-06-20 2023-11-29 Axon Therapies, Inc. Devices for endovascular ablation of a splanchnic nerve
US11554214B2 (en) 2019-06-26 2023-01-17 Meditrina, Inc. Fluid management system
US10792469B1 (en) 2019-08-14 2020-10-06 Vasoinnovations Inc. Devices, systems, and methods for delivering catheters or other medical devices to locations within a patients body
US20210220626A1 (en) 2019-08-14 2021-07-22 Vasoinnovations, Inc. Apparatus and method for advancing catheters or other medical devices through a lumen
US10773059B1 (en) * 2019-08-14 2020-09-15 Vasoinnovations, Inc. Apparatus and method for advancing catheters or other medical devices through a lumen
US10828470B1 (en) 2019-08-14 2020-11-10 Vasoinnovations Inc. Apparatus and method for advancing catheters or other medical devices through a lumen
EP4025287A1 (en) 2019-09-06 2022-07-13 Aria CV, Inc. Diffusion and infusion resistant implantable devices for reducing pulsatile pressure
AU2020354380A1 (en) 2019-09-24 2022-04-07 Shockwave Medical, Inc. System for treating thrombus in body lumens
US11413090B2 (en) 2020-01-17 2022-08-16 Axon Therapies, Inc. Methods and devices for endovascular ablation of a splanchnic nerve
EP4132385A1 (en) * 2020-04-08 2023-02-15 Boston Scientific Scimed, Inc. Medical instrument having a balloon and an extraction member
CN113616315B (en) * 2021-07-28 2023-03-10 华东理工大学 Pulse ablation method capable of increasing ablation area and controlling ablation direction and liquid electrode

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0768097A2 (en) * 1995-10-11 1997-04-16 Terumo Kabushiki Kaisha Catheter balloon and balloon catheter
US5738901A (en) * 1993-09-20 1998-04-14 Scimed Life Systems, Inc. Catheter balloon with retraction coating
US20020082553A1 (en) * 2000-12-22 2002-06-27 Advanced Cardiovascular Systems, Inc. Balloon designs for angioplasty

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4799479A (en) * 1984-10-24 1989-01-24 The Beth Israel Hospital Association Method and apparatus for angioplasty
US4643186A (en) * 1985-10-30 1987-02-17 Rca Corporation Percutaneous transluminal microwave catheter angioplasty
US5191883A (en) * 1988-10-28 1993-03-09 Prutech Research And Development Partnership Ii Device for heating tissue in a patient's body
US4979948A (en) * 1989-04-13 1990-12-25 Purdue Research Foundation Method and apparatus for thermally destroying a layer of an organ
US5114423A (en) * 1989-05-15 1992-05-19 Advanced Cardiovascular Systems, Inc. Dilatation catheter assembly with heated balloon
US5236413B1 (en) * 1990-05-07 1996-06-18 Andrew J Feiring Method and apparatus for inducing the permeation of medication into internal tissue
GB9109068D0 (en) 1991-04-25 1991-06-12 Beam Tech Ltd Tubular device with hydrophilic surface
US5318531A (en) * 1991-06-11 1994-06-07 Cordis Corporation Infusion balloon catheter
US5522873A (en) * 1991-12-26 1996-06-04 Webster Laboratories, Inc. Catheter having electrode with annular recess and method of using same
US5562720A (en) * 1992-05-01 1996-10-08 Vesta Medical, Inc. Bipolar/monopolar endometrial ablation device and method
US5334193A (en) * 1992-11-13 1994-08-02 American Cardiac Ablation Co., Inc. Fluid cooled ablation catheter
US5860974A (en) * 1993-07-01 1999-01-19 Boston Scientific Corporation Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft
US5840076A (en) * 1996-04-12 1998-11-24 Ep Technologies, Inc. Tissue heating and ablation systems and methods using electrode structures with distally oriented porous regions
US5991650A (en) * 1993-10-15 1999-11-23 Ep Technologies, Inc. Surface coatings for catheters, direct contacting diagnostic and therapeutic devices
US5797903A (en) * 1996-04-12 1998-08-25 Ep Technologies, Inc. Tissue heating and ablation systems and methods using porous electrode structures with electrically conductive surfaces
US5549851A (en) * 1994-01-25 1996-08-27 Shin-Etsu Chemical Co., Ltd. Conductive polymer composition
US5462545A (en) * 1994-01-31 1995-10-31 New England Medical Center Hospitals, Inc. Catheter electrodes
US5415636A (en) * 1994-04-13 1995-05-16 Schneider (Usa) Inc Dilation-drug delivery catheter
US5505730A (en) * 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus
US5879348A (en) * 1996-04-12 1999-03-09 Ep Technologies, Inc. Electrode structures formed from flexible, porous, or woven materials
US5925038A (en) * 1996-01-19 1999-07-20 Ep Technologies, Inc. Expandable-collapsible electrode structures for capacitive coupling to tissue
US5846239A (en) * 1996-04-12 1998-12-08 Ep Technologies, Inc. Tissue heating and ablation systems and methods using segmented porous electrode structures
US5891136A (en) * 1996-01-19 1999-04-06 Ep Technologies, Inc. Expandable-collapsible mesh electrode structures
US5961513A (en) * 1996-01-19 1999-10-05 Ep Technologies, Inc. Tissue heating and ablation systems and methods using porous electrode structures
US6475213B1 (en) * 1996-01-19 2002-11-05 Ep Technologies, Inc. Method of ablating body tissue
WO1997025918A1 (en) * 1996-01-19 1997-07-24 Ep Technologies, Inc. Electrode structures formed from flexible, porous, or woven materials
US6071278A (en) * 1996-02-28 2000-06-06 Ep Technologies, Inc. Tissue heating and ablation systems and methods using porous electrode structures with specified electrical resistivities
US5800482A (en) * 1996-03-06 1998-09-01 Cardiac Pathways Corporation Apparatus and method for linear lesion ablation
US6032077A (en) * 1996-03-06 2000-02-29 Cardiac Pathways Corporation Ablation catheter with electrical coupling via foam drenched with a conductive fluid
US5769880A (en) * 1996-04-12 1998-06-23 Novacept Moisture transport system for contact electrocoagulation
US6077273A (en) * 1996-08-23 2000-06-20 Scimed Life Systems, Inc. Catheter support for stent delivery
US6012457A (en) * 1997-07-08 2000-01-11 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6024740A (en) * 1997-07-08 2000-02-15 The Regents Of The University Of California Circumferential ablation device assembly
US6251109B1 (en) * 1997-06-27 2001-06-26 Daig Corporation Process and device for the treatment of atrial arrhythmia
US5997532A (en) * 1997-07-03 1999-12-07 Cardiac Pathways Corporation Ablation catheter tip with a buffer layer covering the electrode
US6241666B1 (en) * 1997-07-03 2001-06-05 Cardiac Pathways Corp. Ablation catheter tip with a buffer layer covering the electrode
US6117101A (en) * 1997-07-08 2000-09-12 The Regents Of The University Of California Circumferential ablation device assembly
US6547788B1 (en) * 1997-07-08 2003-04-15 Atrionx, Inc. Medical device with sensor cooperating with expandable member
US6500174B1 (en) * 1997-07-08 2002-12-31 Atrionix, Inc. Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US6080151A (en) * 1997-07-21 2000-06-27 Daig Corporation Ablation catheter
US6017997A (en) * 1997-10-31 2000-01-25 The B. F. Goodrich Company Waterborne polyurethane having film properties comparable to rubber
GB2331717B (en) * 1997-11-26 1999-12-22 Ranier Ltd Reticulated coatings
US6287314B1 (en) * 1998-04-21 2001-09-11 Advanced Cardiovascular Systems, Inc. Stent deploying catheter system
US6327505B1 (en) * 1998-05-07 2001-12-04 Medtronic, Inc. Method and apparatus for rf intraluminal reduction and occlusion
US6527767B2 (en) * 1998-05-20 2003-03-04 New England Medical Center Cardiac ablation system and method for treatment of cardiac arrhythmias and transmyocardial revascularization
US6123718A (en) * 1998-11-02 2000-09-26 Polymerex Medical Corp. Balloon catheter
US6488658B1 (en) * 1999-06-29 2002-12-03 Ethicon Endo-Surgery, Inc. Method of treating the inner lining of an organ using a bipolar electrosurgical instrument including a plurality of balloon electrodes
CA2379670A1 (en) * 1999-08-12 2001-02-22 Wilson-Cook Medical Inc. Dilation balloon having multiple diameters
US6315778B1 (en) * 1999-09-10 2001-11-13 C. R. Bard, Inc. Apparatus for creating a continuous annular lesion
US6546935B2 (en) * 2000-04-27 2003-04-15 Atricure, Inc. Method for transmural ablation
EP1284776A1 (en) * 2000-05-26 2003-02-26 Wallsten Medical S.A. Balloon catheter

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5738901A (en) * 1993-09-20 1998-04-14 Scimed Life Systems, Inc. Catheter balloon with retraction coating
EP0768097A2 (en) * 1995-10-11 1997-04-16 Terumo Kabushiki Kaisha Catheter balloon and balloon catheter
US20020082553A1 (en) * 2000-12-22 2002-06-27 Advanced Cardiovascular Systems, Inc. Balloon designs for angioplasty

Also Published As

Publication number Publication date
US20050059965A1 (en) 2005-03-17
US7736362B2 (en) 2010-06-15

Similar Documents

Publication Publication Date Title
US7736362B2 (en) Catheter balloons
US5447497A (en) Balloon catheter having nonlinear compliance curve and method of using
US7553292B2 (en) Device for treating vulnerable plaque
US5891027A (en) Cardiovascular catheter system with an inflatable soft tip
US6016437A (en) Catheter probe system with inflatable soft shafts
JP4053882B2 (en) Drug delivery catheter with a highly compliant balloon having an injection hole
US7785289B2 (en) Catheter with flexible, non-kinking elongate member
AU2012308557B2 (en) Ablation device with multiple ablation modes
US6893437B2 (en) Microporous electrode structure and method of making the same
US6086581A (en) Large surface cardiac ablation catheter that assumes a low profile during introduction into the heart
AU2012308464B2 (en) Ablation device with ionically conductive balloon
US4822345A (en) Controllable flexibility catheter
US6344045B1 (en) Sizing and therapeutic catheter with sheath
JP2736823B2 (en) Automatic local perfusion inflation catheter
JP3659664B2 (en) Medical tube
EP1062966A1 (en) Balloon for dilating a stricture and balloon catheter
WO1999020324A1 (en) Helical spiral balloon catheter
JP2010537680A (en) Minimally invasive endovascular treatment device
WO1989005165A1 (en) Improved vascular dilation catheter construction
IL166908A (en) Catheter balloon having improved balloon bonding
WO2002011805A1 (en) Catheter for radiation therapy
CN114887204A (en) Balloon catheter
JPH069612B2 (en) Operable catheter
WO2003039628A2 (en) Balloon catheter with non-slip balloon
JPH067428A (en) Catheter

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase